Biota Focuses on the Future

19:00 EST 29 Dec 2008 | PharmaTelevision

As one of the longest surviving Australian biotech companies, Biota Holdings has a varied and high profiled history. Dr Leigh Farrell talks of the future of the company following the recent litigation process and settlement with GSK and how the company is back strongly focusing its resources on its drug discovery pipeline. For a cash strong company, like Biota, he sees the economic climate as an opportunity to build and he intends to make the most of it, seeking quality opportunities during his international travels.

Original Article: Biota Focuses on the Future


More From BioPortfolio on "Biota Focuses on the Future"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...